JP2001500148A - 1―ブチル―4―ピペリジニルメチルアミンの製造 - Google Patents
1―ブチル―4―ピペリジニルメチルアミンの製造Info
- Publication number
- JP2001500148A JP2001500148A JP10513283A JP51328398A JP2001500148A JP 2001500148 A JP2001500148 A JP 2001500148A JP 10513283 A JP10513283 A JP 10513283A JP 51328398 A JP51328398 A JP 51328398A JP 2001500148 A JP2001500148 A JP 2001500148A
- Authority
- JP
- Japan
- Prior art keywords
- butyl
- toluene
- isonipecotamide
- piperidinylmethylamine
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- SXSSVNBOMMHRRB-UHFFFAOYSA-N (1-butylpiperidin-4-yl)methanamine Chemical compound CCCCN1CCC(CN)CC1 SXSSVNBOMMHRRB-UHFFFAOYSA-N 0.000 title claims description 9
- 238000002360 preparation method Methods 0.000 title claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims abstract description 57
- DPBWFNDFMCCGGJ-UHFFFAOYSA-N 4-Piperidine carboxamide Chemical compound NC(=O)C1CCNCC1 DPBWFNDFMCCGGJ-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 8
- MPPPKRYCTPRNTB-UHFFFAOYSA-N 1-bromobutane Chemical compound CCCCBr MPPPKRYCTPRNTB-UHFFFAOYSA-N 0.000 claims abstract description 7
- -1 1-butyl-4-piperidinylmethyl amine Chemical class 0.000 claims abstract description 6
- 229910010082 LiAlH Inorganic materials 0.000 claims abstract description 6
- 239000002904 solvent Substances 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 7
- 239000011541 reaction mixture Substances 0.000 claims description 4
- KMAKOBLIOCQGJP-UHFFFAOYSA-N indole-3-carboxylic acid Chemical class C1=CC=C2C(C(=O)O)=CNC2=C1 KMAKOBLIOCQGJP-UHFFFAOYSA-N 0.000 claims description 3
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 2
- ADDHGWQXAWKIIL-UHFFFAOYSA-N 3,4-dihydro-2h-[1,3]oxazino[3,2-a]indole Chemical compound C1=CC=C2N(CCCO3)C3=CC2=C1 ADDHGWQXAWKIIL-UHFFFAOYSA-N 0.000 claims 1
- 230000021615 conjugation Effects 0.000 claims 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 238000010533 azeotropic distillation Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LSGKMZLPZFPAIN-UHFFFAOYSA-N 1h-indole-3-carboxamide Chemical compound C1=CC=C2C(C(=O)N)=CNC2=C1 LSGKMZLPZFPAIN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- SDNVJMZXSOXXQN-UHFFFAOYSA-N 3,4-ditert-butyl-2-methylphenol Chemical compound CC1=C(O)C=CC(C(C)(C)C)=C1C(C)(C)C SDNVJMZXSOXXQN-UHFFFAOYSA-N 0.000 description 1
- RQFUZUMFPRMVDX-UHFFFAOYSA-N 3-Bromo-1-propanol Chemical compound OCCCBr RQFUZUMFPRMVDX-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- FXCLGAGFIKPOQS-UHFFFAOYSA-N n-[(1-butylpiperidin-4-yl)methyl]-1h-indole-3-carboxamide Chemical compound C1CN(CCCC)CCC1CNC(=O)C1=CNC2=CC=CC=C12 FXCLGAGFIKPOQS-UHFFFAOYSA-N 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- KVCSJPATKXABRQ-UHFFFAOYSA-N piboserod Chemical compound C1CN(CCCC)CCC1CNC(=O)C(C1=CC=CC=C11)=C2N1CCCO2 KVCSJPATKXABRQ-UHFFFAOYSA-N 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003523 serotonin 4 antagonist Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Optical Couplings Of Light Guides (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. i)イソニペコタミドおよび1−ブロモブタンを反応させ、イソニペコタ ミドのN−ブチル誘導体を得て;ついで、 ii)LiAlH4で還元する ことを含む1−ブチル−4−ピペリジニルメチルアミンの製造方法であって、反 応i)およびii)を溶媒としてトルエン中で行うことを特徴とする方法。 2. 還元後の反応混合物を水酸化ナトリウム加温溶液で処理し、混合物を有機 溶媒で抽出する、請求項1記載の方法。 3. 請求項1記載の方法により1−ブチル−4−ピペリジニルメチルアミンを 製造し、ついで適当なインドール3−カルボン酸誘導体と結合させ、その後、必 要ならばインドールおよび/または置換体を変換すること(3,4−ジヒドロ− 2H−[1,3]オキサジノ[3,2−a]インドールに環化することを含む) を含む、SB207266またはその医薬上許容される塩の製造方法。 4. 請求項3記載の方法により製造されるSB207266。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9618967.5A GB9618967D0 (en) | 1996-09-11 | 1996-09-11 | Pharmaceuticals |
GB9618967.5 | 1996-09-11 | ||
PCT/EP1997/005167 WO1998011067A1 (en) | 1996-09-11 | 1997-09-09 | Preparation of 1-butyl-4-piperidinylmethylamine |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004380260A Division JP2005220126A (ja) | 1996-09-11 | 2004-12-28 | 1−ブチル−4−ピペリジニルメチルアミンの製造法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001500148A true JP2001500148A (ja) | 2001-01-09 |
JP3748570B2 JP3748570B2 (ja) | 2006-02-22 |
Family
ID=10799764
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51328398A Expired - Fee Related JP3748570B2 (ja) | 1996-09-11 | 1997-09-09 | 1―ブチル―4―ピペリジニルメチルアミンの製造 |
JP2004380260A Pending JP2005220126A (ja) | 1996-09-11 | 2004-12-28 | 1−ブチル−4−ピペリジニルメチルアミンの製造法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004380260A Pending JP2005220126A (ja) | 1996-09-11 | 2004-12-28 | 1−ブチル−4−ピペリジニルメチルアミンの製造法 |
Country Status (30)
Country | Link |
---|---|
US (1) | US6331631B1 (ja) |
EP (1) | EP0927163B1 (ja) |
JP (2) | JP3748570B2 (ja) |
KR (1) | KR100525703B1 (ja) |
CN (1) | CN1102927C (ja) |
AR (1) | AR008174A1 (ja) |
AT (1) | ATE358121T1 (ja) |
AU (1) | AU725210B2 (ja) |
BR (1) | BR9712014A (ja) |
CA (1) | CA2266468C (ja) |
CO (1) | CO4930263A1 (ja) |
CY (1) | CY2590B2 (ja) |
CZ (1) | CZ290932B6 (ja) |
DE (1) | DE69737529T2 (ja) |
DK (1) | DK0927163T3 (ja) |
ES (1) | ES2285732T3 (ja) |
GB (1) | GB9618967D0 (ja) |
HK (1) | HK1020963A1 (ja) |
HU (1) | HUP9904155A3 (ja) |
IL (1) | IL128785A0 (ja) |
NO (1) | NO312587B1 (ja) |
NZ (1) | NZ334272A (ja) |
PL (1) | PL191373B1 (ja) |
PT (1) | PT927163E (ja) |
SA (1) | SA97180387B1 (ja) |
SI (1) | SI0927163T1 (ja) |
TR (1) | TR199900493T2 (ja) |
TW (1) | TW432048B (ja) |
WO (1) | WO1998011067A1 (ja) |
ZA (1) | ZA978087B (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9618967D0 (en) * | 1996-09-11 | 1996-10-23 | Smithkline Beecham Plc | Pharmaceuticals |
US20020091271A1 (en) | 1998-07-16 | 2002-07-11 | Smithkline Beecham Plc | Process for the preparation of an indole derivative |
GB0211230D0 (en) | 2002-05-16 | 2002-06-26 | Medinnova Sf | Treatment of heart failure |
CN104557672B (zh) * | 2015-01-26 | 2016-09-21 | 湖南华腾制药有限公司 | 一种1位取代哌啶衍生物的制备方法 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51125373A (en) * | 1975-04-04 | 1976-11-01 | Sumitomo Chem Co Ltd | A process for preparing novel methano-anthracene derivatine |
JPH02212471A (ja) * | 1988-12-12 | 1990-08-23 | Ciba Geigy Ag | ピペリジン誘導体 |
JPH04270257A (ja) * | 1990-08-14 | 1992-09-25 | Chem Linz Ag | 尿素類のn−アルキル化法 |
JPH06510537A (ja) * | 1991-09-12 | 1994-11-24 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5−ht4レセプター・アンタゴニスト |
JPH07504433A (ja) * | 1992-03-12 | 1995-05-18 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5ht↓4−受容体アンタゴニストとしての縮合インドール誘導体 |
JPH07507277A (ja) * | 1992-05-06 | 1995-08-10 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ピペリジンジオン誘導体の立体特異的加水分解方法 |
JPH08502283A (ja) * | 1992-10-16 | 1996-03-12 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5−ht▲下4▼レセプターアンタゴニスト用の縮合環系n−アルキルピペリジニル−4−メチルカルボン酸エステル/アミド |
JPH08113581A (ja) * | 1994-08-05 | 1996-05-07 | Hoechst Ag | ホスフィン類化合物、その製造方法及びその使用方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA22647A1 (fr) * | 1991-09-14 | 1993-04-01 | Smithkline Beecham Plc | Procede de preparation d'un ester ou d'un amide d'un nouveau produit . |
EP0829474B1 (en) | 1995-05-31 | 2003-04-09 | Nisshin Seifun Group Inc. | Indazole derivatives having monocyclic amino group |
GB9618967D0 (en) * | 1996-09-11 | 1996-10-23 | Smithkline Beecham Plc | Pharmaceuticals |
-
1996
- 1996-09-11 GB GBGB9618967.5A patent/GB9618967D0/en active Pending
-
1997
- 1997-09-04 CO CO97051291A patent/CO4930263A1/es unknown
- 1997-09-09 DE DE69737529T patent/DE69737529T2/de not_active Expired - Lifetime
- 1997-09-09 ES ES97910322T patent/ES2285732T3/es not_active Expired - Lifetime
- 1997-09-09 AU AU47764/97A patent/AU725210B2/en not_active Ceased
- 1997-09-09 CA CA002266468A patent/CA2266468C/en not_active Expired - Fee Related
- 1997-09-09 DK DK97910322T patent/DK0927163T3/da active
- 1997-09-09 CN CN97197756A patent/CN1102927C/zh not_active Expired - Fee Related
- 1997-09-09 SI SI9730763T patent/SI0927163T1/sl unknown
- 1997-09-09 KR KR10-1999-7001990A patent/KR100525703B1/ko not_active IP Right Cessation
- 1997-09-09 IL IL12878597A patent/IL128785A0/xx not_active IP Right Cessation
- 1997-09-09 PL PL332088A patent/PL191373B1/pl not_active IP Right Cessation
- 1997-09-09 AT AT97910322T patent/ATE358121T1/de active
- 1997-09-09 CZ CZ1999809A patent/CZ290932B6/cs not_active IP Right Cessation
- 1997-09-09 PT PT97910322T patent/PT927163E/pt unknown
- 1997-09-09 HU HU9904155A patent/HUP9904155A3/hu unknown
- 1997-09-09 JP JP51328398A patent/JP3748570B2/ja not_active Expired - Fee Related
- 1997-09-09 BR BR9712014A patent/BR9712014A/pt active Search and Examination
- 1997-09-09 NZ NZ334272A patent/NZ334272A/xx unknown
- 1997-09-09 TR TR1999/00493T patent/TR199900493T2/xx unknown
- 1997-09-09 WO PCT/EP1997/005167 patent/WO1998011067A1/en active IP Right Grant
- 1997-09-09 AR ARP970104108A patent/AR008174A1/es active IP Right Grant
- 1997-09-09 EP EP97910322A patent/EP0927163B1/en not_active Expired - Lifetime
- 1997-09-09 ZA ZA978087A patent/ZA978087B/xx unknown
- 1997-09-10 TW TW086113072A patent/TW432048B/zh not_active IP Right Cessation
- 1997-09-10 SA SA97180387A patent/SA97180387B1/ar unknown
-
1999
- 1999-03-10 NO NO19991148A patent/NO312587B1/no not_active IP Right Cessation
-
2000
- 2000-01-04 HK HK00100041A patent/HK1020963A1/xx not_active IP Right Cessation
- 2000-08-22 US US09/643,644 patent/US6331631B1/en not_active Expired - Fee Related
-
2004
- 2004-12-28 JP JP2004380260A patent/JP2005220126A/ja active Pending
-
2008
- 2008-02-29 CY CY0800005A patent/CY2590B2/xx unknown
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS51125373A (en) * | 1975-04-04 | 1976-11-01 | Sumitomo Chem Co Ltd | A process for preparing novel methano-anthracene derivatine |
JPH02212471A (ja) * | 1988-12-12 | 1990-08-23 | Ciba Geigy Ag | ピペリジン誘導体 |
JPH04270257A (ja) * | 1990-08-14 | 1992-09-25 | Chem Linz Ag | 尿素類のn−アルキル化法 |
JPH06510537A (ja) * | 1991-09-12 | 1994-11-24 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5−ht4レセプター・アンタゴニスト |
JPH07504433A (ja) * | 1992-03-12 | 1995-05-18 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5ht↓4−受容体アンタゴニストとしての縮合インドール誘導体 |
JPH07507277A (ja) * | 1992-05-06 | 1995-08-10 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | ピペリジンジオン誘導体の立体特異的加水分解方法 |
JPH08502283A (ja) * | 1992-10-16 | 1996-03-12 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5−ht▲下4▼レセプターアンタゴニスト用の縮合環系n−アルキルピペリジニル−4−メチルカルボン酸エステル/アミド |
JPH08113581A (ja) * | 1994-08-05 | 1996-05-07 | Hoechst Ag | ホスフィン類化合物、その製造方法及びその使用方法 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2006502121A (ja) | 1H−イミダゾ[4,5−c]キノリン−4−フタルイミド中間体を介する1H−イミダゾ−[4,5−c]キノリン−4−アミンの調製 | |
EP0167901B1 (en) | Active compounds | |
US4314943A (en) | Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanols | |
JP2000516240A (ja) | N―[(1―▲上n▼ブチル―4―ピペリジル)メチル]―3,4―ジヒドロ―2H―[1,3]オキサジノ[3,2―a]インドール―10―カルボキシアミドおよび塩ならびに製造における中間体 | |
US6706890B2 (en) | Method for producing oxindoles | |
JP2002505999A (ja) | 新規な四環化合物、その製造方法およびこれらの化合物を含有する医薬製剤 | |
JP3748570B2 (ja) | 1―ブチル―4―ピペリジニルメチルアミンの製造 | |
JP4034339B2 (ja) | インダゾール−3−カルボキシアミド誘導体の製造方法 | |
US6946565B2 (en) | Process for the preparation of an indole derivative | |
CA2337382C (en) | Process for the preparation of an indole derivative | |
JP3842555B2 (ja) | インドール誘導体の製造方法 | |
JPS62155272A (ja) | 置換4−フルオロ−イソインドリン類、それらの製造方法及び使用並びにそれらの化合物を含有する調合剤 | |
KR900005021B1 (ko) | 1-펜옥시-3-히드록시 인돌릴 알킬아미노-3-프로판올류 및 그 제조방법 | |
KR820000497B1 (ko) | 신규한 인돌로(2, 3-a)퀴놀리지딘류의 제조방법 | |
JPH09241256A (ja) | N−(1−置換−アザシクロアルカン−3−イル)−6−メトキシ−1h−ベンゾトリアゾール−5−カルボキサミド誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040122 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20040928 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041228 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20051108 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20051129 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081209 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091209 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101209 Year of fee payment: 5 |
|
LAPS | Cancellation because of no payment of annual fees |